PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2025 | $10.6M | $97.1M | $63.0M |
| Jun 2025 | $10.9M | $104.7M | $54.7M |
| Sep 2025 | $0 | $115.3M | $53.5M |
| Dec 2025 | $0 | $130.3M | $29.6M |
| Mar 2026 | $0 | $128.4M | $36.2M |
| Jun 2026 | $0 | $138.5M | $36.5M |